Creative Medical TechnologyCELZ
13F holders, Q3 2025 (September 30)12holders
4new positions
4sold out
$3.30avg. 13F price*
At the end of Q3 2025, 12 institutions reported holding Creative Medical Technology (CELZ) in their 13F filings, unchanged from Q2 2025. 4 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($85K), Geode Capital Management, LLC ($77K) and DRW Securities, LLC ($50K).
- Company
- Creative Medical Technology
- CUSIP
- 22529Y408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $54K |
| Exits | 4 | $69K |
All 13F filers, Q2 2025 → Q3 2025: 26,935 shares bought and 26,159 shares sold, net +776 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Vanguard Group Inc. | 0.00% | Add +46.7% | 25,868 | $85K |
| Geode Capital Management, LLC | 0.00% | Add +11.4% | 23,256 | $77K |
| DRW Securities, LLC | 0.00% | New | 15,101 | $50K |
| Allworth Financial LP | 0.00% | No change | 4,000 | $13K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,130 | $4K |
| Jones Financial Companies LLLP | 0.00% | New | 1,000 | $3K |
| FMR LLC | 0.00% | New | 200 | $658 |
| Bank of America Corp. | 0.00% | Reduce -1.5% | 131 | $436 |
| Morgan Stanley | 0.00% | Add +70.0% | 34 | $113 |
| UBS Group AG | 0.00% | No change | 2 | $7 |
| SBI Securities Co., Ltd. | 0.00% | New | 1 | $3 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is CELZ's weight in each manager's 13F, not the share of Creative Medical Technology the manager owns.